TY - JOUR
T1 - Assessment of contraceptive use and side effects among women in five countries across the Middle East
T2 - a cross-sectional study
AU - Ramadan, Azza
AU - Jarab, Anan S.
AU - Al Meslamani, Ahmad Z.
AU - Ahmed Mohamed Moustafa, Hebatallah
AU - Kassem, Amira B.
AU - Mohammed, Abuelnor
AU - Osman, Wael
AU - Ibrahim, Reem
AU - Alzoubi, Karem H.
N1 - Publisher Copyright:
© 2025 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2025
Y1 - 2025
N2 - Purpose: Contraceptive use and associated adverse effects are underreported in the Middle East. This study aimed to investigate contraceptive use and reported side effects in five Middle Eastern countries. Methods: This study, conducted over eight weeks in the UAE, Egypt, Jordan, Syria, and Iraq, utilized an online closed-ended structured questionnaire to extract the study information. Reproductive-age women were surveyed about hormonal and non-hormonal contraceptive usage practices, frequency, types, and severity of contraceptive-associated side effects. Logistic regression analysis was utilized to determine the predictors of the occurrence of side effects associated with contraceptive use. Results: The prevalence of contraceptive use was 81.2% (1069/1317). The most common contraceptive methods were combined oral contraceptive pills (46.6%, 511/1069), mini pills (15.4%, 169/1069), and hormonal loops (13.8%, 151/1069). The prevalence of contraceptive-associated side effects was 41.9% (448/1069). The commonly reported mild-to-moderate side effects were irregular menstrual bleeding (87.9%), headaches (88.2%), and mood changes (93.5%). Interestingly, the participants living in Egypt (AOR: 14.58, 95% CI: 4.67–45.53, p = 0.012) and Iraq (AOR: 25.71, 95% CI: 9.93–66.60, p = 0.001) had greater odds of developing contraceptive-related side effects than did their counterparts. Breastfeeding (AOR: 0.43, 95% CI: 0.20–0.92, p = 0.03), hypertension (AOR: 0.50, 95% CI: 0.26–0.99, p = 0.047), and smoking (AOR: 0.43, 95% CI: 0.20–0.90, p = 0.027) status reduced the risk of side effects. Surprisingly, healthcare follow-ups significantly increased the risk of side effects among contraceptive users (AOR: 3.48, 95% CI: 2.03–5.97; p = 0.001). Conclusion: Many contraceptive users reported experiencing side effects, which are predominantly mild to moderate. This underscores the need for improved patient education and follow-up, especially in Egypt and Iraq.
AB - Purpose: Contraceptive use and associated adverse effects are underreported in the Middle East. This study aimed to investigate contraceptive use and reported side effects in five Middle Eastern countries. Methods: This study, conducted over eight weeks in the UAE, Egypt, Jordan, Syria, and Iraq, utilized an online closed-ended structured questionnaire to extract the study information. Reproductive-age women were surveyed about hormonal and non-hormonal contraceptive usage practices, frequency, types, and severity of contraceptive-associated side effects. Logistic regression analysis was utilized to determine the predictors of the occurrence of side effects associated with contraceptive use. Results: The prevalence of contraceptive use was 81.2% (1069/1317). The most common contraceptive methods were combined oral contraceptive pills (46.6%, 511/1069), mini pills (15.4%, 169/1069), and hormonal loops (13.8%, 151/1069). The prevalence of contraceptive-associated side effects was 41.9% (448/1069). The commonly reported mild-to-moderate side effects were irregular menstrual bleeding (87.9%), headaches (88.2%), and mood changes (93.5%). Interestingly, the participants living in Egypt (AOR: 14.58, 95% CI: 4.67–45.53, p = 0.012) and Iraq (AOR: 25.71, 95% CI: 9.93–66.60, p = 0.001) had greater odds of developing contraceptive-related side effects than did their counterparts. Breastfeeding (AOR: 0.43, 95% CI: 0.20–0.92, p = 0.03), hypertension (AOR: 0.50, 95% CI: 0.26–0.99, p = 0.047), and smoking (AOR: 0.43, 95% CI: 0.20–0.90, p = 0.027) status reduced the risk of side effects. Surprisingly, healthcare follow-ups significantly increased the risk of side effects among contraceptive users (AOR: 3.48, 95% CI: 2.03–5.97; p = 0.001). Conclusion: Many contraceptive users reported experiencing side effects, which are predominantly mild to moderate. This underscores the need for improved patient education and follow-up, especially in Egypt and Iraq.
KW - Contraceptives
KW - middle East
KW - reproductive health
KW - side effects
UR - https://www.scopus.com/pages/publications/105000368404
U2 - 10.1080/03007995.2025.2472907
DO - 10.1080/03007995.2025.2472907
M3 - Article
C2 - 39996477
AN - SCOPUS:105000368404
SN - 0300-7995
VL - 41
SP - 569
EP - 578
JO - Current Medical Research and Opinion
JF - Current Medical Research and Opinion
IS - 3
ER -